Brain Res Bull. 2016 Sep;126(Pt 1):68-73. doi: 10.1016/j.brainresbull.2016.05.016. Epub 2016 May 31.
PMID:27261367
Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation.
McIntyre RS, Rosenblat JD, Nemeroff CB, Sanacora G, Murrough JW, Berk M, Brietzke E, Dodd S, Gorwood P, Ho R, Iosifescu DV, Lopez Jaramillo C, Kasper S, Kratiuk K, Lee JG, Lee Y, Lui LMW, Mansur RB, Papakostas GI, Subramaniapillai M, Thase M, Vieta E, Young AH, Zarate CA Jr, Stahl S.
Am J Psychiatry. 2021 May 1;178(5):383-399. doi: 10.1176/appi.ajp.2020.20081251. Epub 2021 Mar 17.
PMID:33726522
Overdoses and deaths related to the use of ketamine and its analogues: a systematic review.
Chaves TV, Wilffert B, Sanchez ZM.
Am J Drug Alcohol Abuse. 2023 Mar 4;49(2):141-150. doi: 10.1080/00952990.2022.2132506. Epub 2022 Nov 21.
PMID:36410032
Ketamine for the treatment of addiction: Evidence and potential mechanisms.
Ivan Ezquerra-Romano I, Lawn W, Krupitsky E, Morgan CJA.
Neuropharmacology. 2018 Nov;142:72-82. doi: 10.1016/j.neuropharm.2018.01.017. Epub 2018 Jan 12.
PMID:29339294
[History of Ketamine: An ancient molecule that is still popular today].
Adjunctive Ketamine With Relapse Prevention-Based Psychological Therapy in the Treatment of Alcohol Use Disorder.
Grabski M, McAndrew A, Lawn W, Marsh B, Raymen L, Stevens T, Hardy L, Warren F, Bloomfield M, Borissova A, Maschauer E, Broomby R, Price R, Coathup R, Gilhooly D, Palmer E, Gordon-Williams R, Hill R, Harris J, Mollaahmetoglu OM, Curran HV, Brandner B, Lingford-Hughes A, Morgan CJA.
Am J Psychiatry. 2022 Feb;179(2):152-162. doi: 10.1176/appi.ajp.2021.21030277. Epub 2022 Jan 11.